Possible immunogenicity of the Cas9 protein raises concerns about therapeutic applications. Here the authors identify pre-existing CD8+T-cell immunity in healthy individuals and in response modify Cas9 to remove the immunodominant epitopes.
- Shayesteh R. Ferdosi
- Radwa Ewaisha
- Karen S. Anderson
